Home
About Us
Newsletter
Contact Us
About Us
Leadership Team
Leadership Team
Mr. Kamal Shanhani
Mr. Rajesh R
Dr Devesh k
Dr Suneet
Dr Sheikh
Dr R Kumar
Mr. Kuldeep Kinja
Mr. Gaurav Grover
Dr. Anu Dambalkar
Mr. Amit Nakhe
Pharma Business Analytics Solutions
Onco-
i
HEOR - (Health Economics Outcomes Research)mes Research
Clinical safety and Pharmacovigilance Services
A. Drug Safety
Single Case Processing
Aggregate Report Writing
Risk Management Plans
Literature Search & Review
PV system master file
MedDRA Coding
B. PV Consulting
QPPV & PVSMF Services
Preparation of guidance documents
Regulatory Assistance
Audit support
C. Safety Database Solution
D. Edvera-Evidex-Signal Detection
Evolution Management Solution
Signal Detection Evolution Management Solution
Press Release
Clinical Trials Services
Clinical Trials Services
The Leadership Team
Our Experience
Therapeutic Areas
Organogram
Medical Writing and Communication Services
White Papers
Abstracts
Clinical Papers/ Journal Articles
Literature Reviews
Proof Reading
Medical Writing Services for Clinical Trials
Posters
Presentations/ Slide kits
CME
Drug Brochures / Product Monographs
Patient Education Services
Newsletters
Think
i
Patient Assistances Services
Query Management
KOL Management Tool
Sales Training
Literature Search Services
Clinical Data Management Services
Biostatistics and Data Analytics Services
Training
Pharmacovigilance
Medical Writing
MedDRA
Phase IV Management
Phase IV Management
Phase IV Management Services
Request a Service
Technology Partner
Dr. Anu Dambalkar
MBBS, Diploma in Pharmacovigilance Senior Drug Safety Physician
Senior Drug Safety Physician with over 7 years of pharmacovigilance and 3 years of clinical experience.
Periodic Benefit Risk Evaluation Reports (PBRERs)/ Periodic Safety Update Reports (PSURs); Periodic Adverse Drug Experience Reports (PADERs); Addendum to Clinical Overview (ACOs); Health Hazard Evaluations (HHEs). Experienced in Case Analysis for Ad Hoc reports and Surveillance Analysis of Non Spontaneous Safety Data for PharmacoVigilance (SNAP)
Experienced in conducting medical review of PBRERs/PSURs, PADERs, HHEs, Ad Hoc Reports, SNAP and Safety Management Team (SMT) Slides which includes checking the case for overall medical cohesiveness, checking the expectedness of adverse events, adding company causality and company comments
Trained in Monthly Signal Reports and Drug Abuse Report for FDA
Maintaining a knowledge of the AE safety profile of assigned drugs, Reference Safety Information documents, aggregate reporting conventions and guidelines, clients’ procedures and international drug safety regulations. Maintaining an awareness of global regulatory reporting obligations.
Experienced in conducting medical review of PBRERs/PSURs, which includes checking the case for overall medical cohesiveness, checking the expectedness of adverse events, adding company causality and company comments.
copyright@think
i
.in, All Rights Reserved,2011
HOME
|
CONTACT US
|
ABOUT US
|
TEAM THINKI
|
PV NEWS
|
Site Map
FOLLOW